CpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates

  • Verthelyi D
  • Kenney R
  • Seder R
  • et al.
191Citations
Citations of this article
90Readers
Mendeley users who have this article in their library.

Abstract

Synthetic oligodeoxynucleotides (ODN) containing unmethylated CpG motifs act as immune adjuvants in mice, boosting the humoral and cellular response to coadministered Ags. CpG ODN that stimulate human PBMC are only weakly active in mice. Thus, alternative animal models are needed to monitor the activity and safety of “human” CpG ODN in vivo. This work demonstrates that rhesus macaques recognize and respond to the same CpG motifs that trigger human immune cells. Coadministering CpG ODN with heat-killed Leishmania vaccine provided significantly increased protection of macaques against cutaneous Leishmania infection. These findings indicate that rhesus macaques provide a useful model for studying the in vivo activity of human CpG motifs, and that ODN expressing these motifs act as strong immune adjuvants.

Cite

CITATION STYLE

APA

Verthelyi, D., Kenney, R. T., Seder, R. A., Gam, A. A., Friedag, B., & Klinman, D. M. (2002). CpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates. The Journal of Immunology, 168(4), 1659–1663. https://doi.org/10.4049/jimmunol.168.4.1659

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free